KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer

By Cicenas Jonas   Kvederaviciute Kotryna   Meskinyte Ingrida   Meskinyte-Kausiliene Edita   Skeberdyte Aiste   Cicenas Jonas  

Cancers, Vol. 9, Iss. 5, 2017-04 ,pp. : 42-42

MDPI

Access to resources Recommend Favorite

Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women

By Querzoli P.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 2, 2001-03 ,pp. : 135-142

Springer Publishing Company

Access to resources Recommend Favorite

Xp22.2-3 Loss of Heterozygosity Is Associated with Germline BRCA1 Mutation in Ovarian Cancer

By Buekers T.E.   Lallas T.A.   Buller R.E.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 418-422

Elsevier

Access to resources Recommend Favorite

Genome-Wide search for loss of heterozygosity in Chinese patients with sporadic colorectal cancer

By Peng Zhihai   Zhang Fang   Zhou Chongzhi   Ling Yun   Bai Shaochun   Liu Wanqing   Qiu Guoqiang   He Lin   Wang Liwei   Wei Daoyan   Lin Edward   Xie Keping  

International Journal of Gastrointestinal Cancer, Vol. 34, Iss. 1, 2003-08 ,pp. : 39-47

Humana Press, Inc

Access to resources Recommend Favorite

Differential Prognosis of Replication Error Phenotype and Loss of Heterozygosity in Sporadic Colorectal Cancer

By Massa M.-J.   Iniesta P.   Gonzalez-Quevedo R.   de Juan C.   Caldes T.   Sanchez-Pernaute A.   Cerdan J.   Torres A.J.   Balibrea J.L.   Benito M.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1676-1682

Elsevier

Access to resources Recommend Favorite